Back

Lp(a), aortic valve stenosis, and atherosclerosis

30 August 2026 (17:42 - 17:54)
Organised by: Logo
Congress Presentation Part of: New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Simon Kraler

University Heart Center, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
Remnant cholesterol and triglyceride-rich lipoproteins: what human genetics tells us about causality beyond LDL
Professor A. Tybjaerg-Hansen (Copenhagen, DK)
Slides Video
Presentation thumbnail
Emerging mechanisms controlling immunoinflammatory response during atherogenesis
Miss M. Depuydt (Amsterdam, NL)
Slides Video
Presentation thumbnail
Targeting deoxyribonucleic acid and ribonucleic acid in the context of lipid-lowering and vascular disorders
Professor N. Bouatia-Naji (Paris, FR)
Slides Video
Presentation thumbnail
New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion
Video

Access the full session

Session thumbnail
New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein?
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:42 CET
You may be interested in
thumbnail
Congress Presentation
Lp(a) and aortic stenosis: biological underpinnings
2 September 2024
thumbnail
Congress Presentation
Targeting lipoprotein(a)
31 August 2026
thumbnail
Congress Presentation
Lp(a): aspirations for treating aortic stenosis.
26 August 2022
thumbnail
Congress Presentation
Deciphering lipoprotein(a) atherogenicity with use of high-throughput proteomics
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources